Understanding the epidemiology of multi-drug resistant gram-negative bacilli in the Middle East using a one health approach

I Dandachi, A Chaddad, J Hanna, J Matta… - Frontiers in …, 2019 - frontiersin.org
In the last decade, extended-spectrum cephalosporin and carbapenem resistant Gram-
negative bacilli (GNB) have been extensively reported in the literature as being …

Optimized Treatment of Nosocomial Peritonitis

JJ De Waele, F Coccolini, L Lagunes, E Maseda… - Antibiotics, 2023 - mdpi.com
This comprehensive review aims to provide a practical guide for intensivists, focusing on
enhancing patient care associated with nosocomial peritonitis (NP). It explores the …

Urinary tract infection caused by extended‐spectrum β‐lactamase‐producing bacteria: Risk factors and antibiotic resistance

JH Albaramki, T Abdelghani, A Dalaeen… - Pediatrics …, 2019 - Wiley Online Library
Background The aim of this study was to investigate the risk factors for acquisition of
extended spectrum β‐lactamase (ESBL)‐producing bacteria in community‐acquired urinary …

Antimicrobial Susceptibilities and Laboratory Profiles of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates as Agents of Urinary Tract Infection …

ES Sokhn, A Salami, A El Roz, L Salloum… - Medical …, 2020 - mdpi.com
Background: Urinary tract infections (UTIs) are major healthcare problems that are usually
treated empirically. However, antimicrobial resistance has been increasing across many …

Development of carboxymethyl cellulose-based hydrogel and nanosilver composite as antimicrobial agents for UTI pathogens

SM Alshehri, A Aldalbahi, AB Al-Hajji… - Carbohydrate …, 2016 - Elsevier
Silver nanoparticles (AgNPs) containing hydrogel composite were first synthesized by
preparing a new hydrogel from carboxymethyl cellulose (CMC), polyvinyl alcohol (PVA), and …

Effective Oral Combination Treatment for Extended-Spectrum Beta-Lactamase-Producing Escherichia coli

M Al-Tamimi, J Abu-Raideh, H Albalawi… - Microbial Drug …, 2019 - liebertpub.com
Background: Extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) is
increasing worldwide. The drugs of choice for treatment of ESBLs are parenteral …

[HTML][HTML] Extended-spectrum β-lactamase producing E. coli in urinary tract infections: A two-center, cross-sectional study of prevalence, genotypes and risk factors in …

SA Al-Jamei, AY Albsoul, FG Bakri… - Journal of infection and …, 2019 - Elsevier
Background To determine the prevalence, phenotypes, and genotypes of extended
spectrum β-lactamase (ESBL)-producing Escherichia coli (E. coli) among patients with …

New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance

LS Syue, YH Chen, WC Ko, PR Hsueh - International journal of …, 2016 - Elsevier
The continuing increase in multidrug-resistant organisms (MDROs) worldwide has created
new challenges in treating complicated intra-abdominal infections (cIAIs). A number of novel …

[HTML][HTML] Detection of CTX-M-15 among uropathogenic Escherichia coli isolated from five major hospitals in Tripoli, Libya

A Zorgani, A Almagatef, N Sufya, A Bashein… - Oman Medical …, 2017 - ncbi.nlm.nih.gov
Objectives Multidrug resistance (MDR) and emergence of extended-spectrum β-lactamases
(ESBLs) among uropathogenic Escherichia coli have been reported worldwide, but there …

Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: A systematic review and meta-analysis of randomized controlled trials

TYT Chen, CK Hsu, SC Shih, TS Weng, HJ Tang… - International Journal of …, 2023 - Elsevier
Background Carbapenem-sparing antibiotics are needed urgently for patients with
complicated intra-abdominal infections (cIAIs). Although several novel antibiotics–novel β …